OpenBilldrug price receipt

NADAC week of 2026-10-14

RAMIPRIL 2.5 MG CAPSULE

For 30 capsules

Pharmacies pay

$1.42 filed

30 × $0.0473 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$3.53 filed

30 × $0.11781 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.5× estimated

Medicare paid 2.5× what pharmacies pay.

Part D averages every strength and form sold under “Ramipril” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$6.63 estimated

$1.42 + $0.21 (15%) + $5.00 fee per fill = $6.63

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

RAMIPRIL 2.5 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as ramipril.

FDA gives its dosage form as capsule and its route as oral.

FDA lists 7 labelers (the companies named on the label) for its NDCs, among them Rising Pharma Holdings, Inc., Chartwell RX, LLC. and Aurobindo Pharma Limited.

FDA’s Established Pharmacologic Class for it is Angiotensin Converting Enzyme Inhibitor.

The NADAC file of 2026-10-14 prices it under 13 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.42 for 30 capsules (30 × $0.0473 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 7 labelers

LabelerNDCsPharmacies pay per unit
Lupin Pharmaceuticals, Inc.4$0.0473 per EA filed
Aurobindo Pharma Limited2$0.0473 per EA filed
Exelan Pharmaceuticals, Inc.2$0.0473 per EA filed
Rising Pharma Holdings, Inc.2$0.0473 per EA filed
BluePoint Laboratories1$0.0473 per EA filed
Chartwell RX, LLC.1$0.0473 per EA filed
Zydus Pharmaceuticals USA Inc.1$0.0473 per EA filed
All 13 NDCs, with labeler and price
  • 57237-0223-01 · Rising Pharma Holdings, Inc. · $0.0473 per EA · eff. 2026-09-23 filed
  • 57237-0223-05 · Rising Pharma Holdings, Inc. · $0.0473 per EA · eff. 2026-09-23 filed
  • 62135-0272-90 · Chartwell RX, LLC. · $0.0473 per EA · eff. 2026-09-23 filed
  • 65862-0475-01 · Aurobindo Pharma Limited · $0.0473 per EA · eff. 2026-09-23 filed
  • 65862-0475-05 · Aurobindo Pharma Limited · $0.0473 per EA · eff. 2026-09-23 filed
  • 68001-0429-00 · BluePoint Laboratories · $0.0473 per EA · eff. 2026-09-23 filed
  • 68180-0589-01 · Lupin Pharmaceuticals, Inc. · $0.0473 per EA · eff. 2026-09-23 filed
  • 68180-0589-02 · Lupin Pharmaceuticals, Inc. · $0.0473 per EA · eff. 2026-09-23 filed
  • 68180-0589-09 · Lupin Pharmaceuticals, Inc. · $0.0473 per EA · eff. 2026-09-23 filed
  • 68180-0589-10 · Lupin Pharmaceuticals, Inc. · $0.0473 per EA · eff. 2026-09-23 filed
  • 68382-0145-01 · Zydus Pharmaceuticals USA Inc. · $0.0473 per EA · eff. 2026-09-23 filed
  • 76282-0671-01 · Exelan Pharmaceuticals, Inc. · $0.0473 per EA · eff. 2026-09-23 filed
  • 76282-0671-05 · Exelan Pharmaceuticals, Inc. · $0.0473 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name ramipril with RAMIPRIL 2.5 MG CAPSULE.

ProductPharmacies pay per unitMedicare per unit
RAMIPRIL 1.25 MG CAPSULE
generic · capsule
$0.08041 per EA filed
eff. 2026-09-23
$0.11781 per EA filed
Part D 2024 average
RAMIPRIL 2.5 MG CAPSULE this page
generic · capsule
$0.0473 per EA filed
eff. 2026-09-23
$0.11781 per EA filed
Part D 2024 average
RAMIPRIL 5 MG CAPSULE
generic · capsule
$0.05141 per EA filed
eff. 2026-09-23
$0.11781 per EA filed
Part D 2024 average
RAMIPRIL 10 MG CAPSULE
generic · capsule
$0.07071 per EA filed
eff. 2026-09-23
$0.11781 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 13 NDCs’ NADAC prices is $0.0473 per EA filed.

Of the 50 other products in FDA’s Angiotensin Converting Enzyme Inhibitor class priced per EA, 42 have a higher middle NADAC price and 8 a lower one. The one in the middle is AMLODIPINE-BENAZEPRIL 5-40 MG, at $0.14392 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $3.53 for 30 capsules, at an average of $0.11781 per EA in 2024 (2024-01-01 to 2024-12-31) for “Ramipril”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 1,539,276 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for RAMIPRIL 2.5 MG CAPSULE labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Ramipril / Ramipril: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.